PUBLISHER: Grand View Research | PRODUCT CODE: 2040468
PUBLISHER: Grand View Research | PRODUCT CODE: 2040468
The global equine genetics market size was estimated at USD 377.2 million in 2025 and is projected to reach USD 686.6 million by 2033, growing at a CAGR of 7.9% from 2026 to 2033. The market is significantly growing, driven by rising adoption of genomic tools in performance horse breeding and selection, regulatory mandates for parentage verification across breed registries, declining sequencing costs, expanding direct-to-consumer testing access, and strategic consolidation accelerating technology access across the value chain.
Genomic testing has become a foundational component of performance horse management, particularly within racing and competitive equine sports. Breed registries, racing authorities, and private breeders are increasingly integrating whole-genome sequencing and SNP-based panels into standard breeding protocols, moving away from phenotype-only selection toward genotype-informed decision-making. The commercial availability of performance-oriented genetic panels has been a significant catalyst. For instance, Etalon Equine Genetics offers DNA-based assessments covering speed aptitude, surface preference, and injury susceptibility, allowing trainers and owners to make data-backed acquisition and breeding decisions. Similarly, Equinome Labs provides Thoroughbred-specific tests evaluating race distance suitability and performance potential, directly influencing breeding pair selection at the highest competitive levels.
Global Equine Genetics Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global equine genetics market report based on type, application, distribution channel, and region: